Patent · US Active

Antibodies that bind peptidoglycan recognition protein 1

US10150809B2 · kind B2 · utility

0Cited by
64References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2017
Grant dateDec 11, 2018
Priority date
Expiry dateApr 10, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein is a method for identifying TREM-1's ligand and antibodies, or fragments thereof, which are capable of modifying the function of TREM-1's ligand. Antibodies that reduce or block TREM-1 activation may be identified and selected using this method. Antibodies that bind to TREM-1's ligand and reduce TREM-1 activity may be suitable for use as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.